Manufacturer of Controlled Substances Registration: Cayman Chemical Company, 32322-32324 [2014-12952]
Download as PDF
<![CDATA[
32322
Federal Register / Vol. 79, No. 107 / Wednesday, June 4, 2014 / Notices
substances to make reference standards
for distribution to their customers.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12972 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
(‘‘Deputy Assistant Administrator’’)
pursuant to sec. 7(g) of 28 CFR part 0,
subpart R, App.
In accordance with 21 CFR
1301.33(a), this is notice that on March
27, 2014, Austin Pharma, LLC., 811
Paloma Drive, Suite C, Round Rock,
Texas 78665–2402, applied to be
registered as a bulk manufacturer of the
following basic classes of controlled
substances:
Drug Enforcement Administration
Controlled substance
Schedule
[Docket No. DEA–392]
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Bulk Manufacturer of Controlled
Substances Application: AUSTIN
PHARMA, LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before August 4, 2014.
ADDRESSES: Written comments should
be to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/ODW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, and
dispensers of controlled substances
(other than final orders in connection
with suspension, denial, or revocation
of registration) has been redelegated to
the Deputy Assistant Administrator of
the DEA Office of Diversion Control
DATES:
I
I
The company plans to manufacture
bulk synthetic active pharmaceutical
ingredients (APIs) for distribution and
new product development to its
customers. The company plans to bulk
manufacture a synthetic
tetrahydrocannabinol.
In reference to drug code 7360, the
company plans to manufacture a
synthetic cannabinol in bulk for sale to
its customers. The controlled substance
will be further synthesized to bulk
manufacture a synthetic
tetrahydrocannabinol (7370). No other
activity for this drug code is authorized
for this registration.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12944 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Cayman
Chemical Company
ACTION:
Cayman Chemical Company
applied to be registered as a
manufacturer of certain basic classes of
narcotic or non-narcotic controlled
substances. The DEA grants Cayman
Chemical Company registration as a
manufacturer of those controlled
substances.
SUMMARY:
By notice
dated December 31, 2013, and
published in the Federal Register on
January 10, 2014, 79 FR 1889, Cayman
Chemical Company, 1180 East Ellsworth
Road, Ann Arbor, Michigan 48108,
applied to be registered as a
manufacturer of certain basic classes of
narcotic or non-narcotic controlled
substances.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823(a) and
determined that the registration of
Cayman Chemical Company to
manufacture the basic classes of
controlled substances is consistent with
the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated the company’s maintenance
of effective controls against diversion by
inspecting and testing the company’s
physical security systems, verified the
company’s compliance with state and
local laws, and reviewed the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the basic classes of
narcotic or non-narcotic controlled
substances listed:
SUPPLEMENTARY INFORMATION:
Notice of registration.
tkelley on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
4-Methyl-N-methylcathinone (1248) ............................................................................................................................................................
N-Ethylamphetamine (1475) ........................................................................................................................................................................
N,N-Dimethylamphetamine (1480) ..............................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
4-Methylaminorex (cis isomer) (1590) .........................................................................................................................................................
Gamma Hydroxybutyric Acid (2010) ...........................................................................................................................................................
JWH-250 (6250) ..........................................................................................................................................................................................
SR-18 also known as RCS-8 (7008) ...........................................................................................................................................................
XLR11 (7011) ..............................................................................................................................................................................................
JWH-019 (7019) ..........................................................................................................................................................................................
AKB48 (7048) ..............................................................................................................................................................................................
JWH-081 (7081) ..........................................................................................................................................................................................
SR-19 also known as RCS-4 (7104) ...........................................................................................................................................................
1-Pentyl-3-(1-naphthoyl)indole (7118) .........................................................................................................................................................
JWH-122 (7122) ..........................................................................................................................................................................................
VerDate Mar<15>2010
16:05 Jun 03, 2014
Jkt 232001
PO 00000
Frm 00110
Fmt 4703
Sfmt 4703
E:\FR\FM\04JNN1.SGM
04JNN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
32323
Federal Register / Vol. 79, No. 107 / Wednesday, June 4, 2014 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
Controlled substance
Schedule
UR-144 (7144) .............................................................................................................................................................................................
1-Butyl-3-(1-naphthoyl)indole (7173) ...........................................................................................................................................................
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole (7200) .............................................................................................................................
AM-2201 (7201) ...........................................................................................................................................................................................
JWH-203 (7203) ..........................................................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-.
3-hydroxycyclohexyl]-phenol (7297) ............................................................................................................................................................
5-(1,1-Dimethyloctyl)-2-[(1R,3S) 3-hydroxycyclohexyl]-phenol (7298) ........................................................................................................
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) ...............................................................................................................................
Marihuana (7360) ........................................................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
Mescaline (7381) .........................................................................................................................................................................................
2C-T-2 (7385) ..............................................................................................................................................................................................
3,4,5-Trimethoxyamphetamine (7390) ........................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine (7391) ..............................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine (7392) ..........................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine (7395) ..............................................................................................................................................
2,5-Dimethoxyamphetamine (7396) ............................................................................................................................................................
JWH-398 (7398) ..........................................................................................................................................................................................
2,5-Dimethoxy-4-ethylamphetamine (7399) ................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine (7401) ..................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (7405) ............................................................................................................................................
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
5-Methoxy-N-N-dimethyltryptamine (7431) .................................................................................................................................................
Alpha-methyltryptamine (7432) ...................................................................................................................................................................
Bufotenine (7433) ........................................................................................................................................................................................
Diethyltryptamine (7434) .............................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine (7439) ..............................................................................................................................................
N-Ethyl-1-phenylcyclohexylamine (7455) ....................................................................................................................................................
N-Benzylpiperazine (7493) ..........................................................................................................................................................................
2C-D (7508) .................................................................................................................................................................................................
2C-E (7509) .................................................................................................................................................................................................
2C-H (7517) .................................................................................................................................................................................................
2C-I (7518) ..................................................................................................................................................................................................
2C-C (7519) .................................................................................................................................................................................................
2C-N (7521) .................................................................................................................................................................................................
2C-P (7524) .................................................................................................................................................................................................
2C-T-4 (7532) ..............................................................................................................................................................................................
MDPV (7535) ...............................................................................................................................................................................................
Methylone (7540) .........................................................................................................................................................................................
AM-694 (7694) .............................................................................................................................................................................................
Desmorphine (9055) ....................................................................................................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Morphine-N-oxide (9307) .............................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Tilidine (9750) ..............................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Lisdexamfetamine (1205) ............................................................................................................................................................................
Pentobarbital (2270) ....................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Phenylacetone (8501) .................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Hydrocodone (9193) ....................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Meperidine intermediate-B (9233) ...............................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) (9273) ..............................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
VerDate Mar<15>2010
16:05 Jun 03, 2014
Jkt 232001
PO 00000
Frm 00111
Fmt 4703
Sfmt 4703
E:\FR\FM\04JNN1.SGM
04JNN1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
32324
Federal Register / Vol. 79, No. 107 / Wednesday, June 4, 2014 / Notices
Controlled substance
Schedule
Sufentanil (9740) .........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
The company plans to manufacture
reference standards for distribution to
their research and forensics customers.
In reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture a synthetic
tetrahydrocannabinol (7370). No other
activity for this drug code is authorized
for this registration.
No comments or objections have been
received.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12952 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Manufacturer of Controlled
Substances Registration: Noramco,
Inc.
ACTION:
Notice of registration.
Noramco, Inc. applied to be
registered as a manufacturer of certain
basic classes of narcotic or non-narcotic
controlled substances. The DEA grants
Noramco, Inc. registration as a
manufacturer of those controlled
substances.
SUPPLEMENTARY INFORMATION: By notice
dated December 23, 2013, and
published in the Federal Register on
January 8, 2014, 79 FR 1390, Noramco,
Inc. (GA), 1440 Olympic Drive, Athens,
Georgia 30601, applied to be registered
as a manufacturer of certain basic
classes of narcotic or non-narcotic
controlled substances.
The Drug Enforcement
Administration (DEA) has considered
the factors in 21 U.S.C. 823(a) and
determined that the registration of
Noramco, Inc. to manufacture the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971. The
DEA investigated the company’s
maintenance of effective controls
against diversion by inspecting and
testing the company’s physical security
tkelley on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:05 Jun 03, 2014
Jkt 232001
systems, verified the company’s
compliance with state and local laws,
and reviewed the company’s
background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above-named company is
granted registration as a bulk
manufacturer of the basic classes of
narcotic or non-narcotic controlled
substances listed:
Controlled substance
Gamma
Hydroxybutyric
Acid
(2010).
Dihydromorphine (9145) ...............
Morphine-N-oxide (9307) .............
Codeine-N-oxide (9053) ...............
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Opium tincture (9630) ..................
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Alfentanil (9737) ...........................
Remifentanil (9739) ......................
Sufentanil (9740) ..........................
Carfentanil (9743) .........................
Tapentadol (9780) ........................
Fentanyl (9801) ............................
Schedule
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014–12954 Filed 6–3–14; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OJP (OJP) Docket No. 1654]
Request for Nominations to the Office
of Justice Programs’ Science Advisory
Board
Office of Justice Programs
(OJP), DOJ.
ACTION: Notice of Request for
Nominations.
AGENCY:
PO 00000
Frm 00112
Fmt 4703
Sfmt 4703
II
II
This notice announces that
OJP is seeking nominations of
individuals to serve on the OJP Science
Advisory Board (‘‘Board’’). The Board
was established by the Attorney General
in 2010. It is chartered to provide OJP,
a component of the Department of
Justice, with valuable advice in the
areas of science and statistics for the
purpose of enhancing the overall impact
and performance of its programs and
activities in criminal and juvenile
justice. To this end, the Board currently
operates with six (6) subcommittees:
National Institute of Justice (NIJ);
Bureau of Justice Statistics (BJS); Office
of Juvenile Justice and Delinquency
Prevention (OJJDP); Bureau of Justice
Assistance (BJA); Quality and Protection
of Science; and Evidence Translation/
Integration.
SUMMARY:
Nominations will be accepted
through August 29, 2014.
DATES:
FOR FURTHER INFORMATION CONTACT:
Phelan Wyrick, Designated Federal
Officer (DFO), Office of the Assistant
Attorney General, Office of Justice
Programs, 810 7th Street Northwest,
Washington, DC 20531; Phone: (202)
353–9254 [Note: this is not a toll-free
number]; Email: phelan.wyrick@
usdoj.gov.
To make a
nomination, please contact Mr. Wyrick
(see above for addresses and phone
numbers). Nominations should include
the name, title, affiliation, and contact
information for the nominee. Resumes,
statements of interest, and other
relevant supporting information are
welcome. Self-nominations are
welcome.
The Board typically meets twice a
year to brief the OJP Assistant Attorney
General and the Board members on the
progress of the subcommittees, discuss
any recommendations they may have for
consideration by the full SAB, and brief
the Board on various OJP-related
projects and activities. All meetings of
the Board take place in Washington, DC.
The Board is a federal advisory
committee covered under the Federal
Advisory Committee Act, and as such,
meetings of the Board are open to the
public. Members of the Board include
scientists and practitioners with strong
backgrounds of applying science in the
fields of criminal justice, juvenile
justice, or crime victim services. Current
SUPPLEMENTARY INFORMATION:
E:\FR\FM\04JNN1.SGM
04JNN1
]]>Agencies
[Federal Register Volume 79, Number 107 (Wednesday, June 4, 2014)]
[Notices]
[Pages 32322-32324]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12952]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Manufacturer of Controlled Substances Registration: Cayman
Chemical Company
ACTION: Notice of registration.
-----------------------------------------------------------------------
SUMMARY: Cayman Chemical Company applied to be registered as a
manufacturer of certain basic classes of narcotic or non-narcotic
controlled substances. The DEA grants Cayman Chemical Company
registration as a manufacturer of those controlled substances.
SUPPLEMENTARY INFORMATION: By notice dated December 31, 2013, and
published in the Federal Register on January 10, 2014, 79 FR 1889,
Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan
48108, applied to be registered as a manufacturer of certain basic
classes of narcotic or non-narcotic controlled substances.
The Drug Enforcement Administration (DEA) has considered the
factors in 21 U.S.C. 823(a) and determined that the registration of
Cayman Chemical Company to manufacture the basic classes of controlled
substances is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971. The DEA investigated the company's
maintenance of effective controls against diversion by inspecting and
testing the company's physical security systems, verified the company's
compliance with state and local laws, and reviewed the company's
background and history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above-named company is granted registration as a bulk
manufacturer of the basic classes of narcotic or non-narcotic
controlled substances listed:
------------------------------------------------------------------------
Controlled substance Schedule
------------------------------------------------------------------------
Cathinone (1235)................................. I
Methcathinone (1237)............................. I
4-Methyl-N-methylcathinone (1248)................ I
N-Ethylamphetamine (1475)........................ I
N,N-Dimethylamphetamine (1480)................... I
Aminorex (1585).................................. I
4-Methylaminorex (cis isomer) (1590)............. I
Gamma Hydroxybutyric Acid (2010)................. I
JWH-250 (6250)................................... I
SR-18 also known as RCS-8 (7008)................. I
XLR11 (7011)..................................... I
JWH-019 (7019)................................... I
AKB48 (7048)..................................... I
JWH-081 (7081)................................... I
SR-19 also known as RCS-4 (7104)................. I
1-Pentyl-3-(1-naphthoyl)indole (7118)............ I
JWH-122 (7122)................................... I
[[Page 32323]]
UR-144 (7144).................................... I
1-Butyl-3-(1-naphthoyl)indole (7173)............. I
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) indole I
(7200).
AM-2201 (7201)................................... I
JWH-203 (7203)................................... I
Alpha-ethyltryptamine (7249)..................... I
5-(1,1-Dimethylheptyl)-2-[(1R,3S)-...............
3-hydroxycyclohexyl]-phenol (7297)............... I
5-(1,1-Dimethyloctyl)-2-[(1R,3S) 3- I
hydroxycyclohexyl]-phenol (7298).
Lysergic acid diethylamide (7315)................ I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine I
(7348).
Marihuana (7360)................................. I
Tetrahydrocannabinols (7370)..................... I
Mescaline (7381)................................. I
2C-T-2 (7385).................................... I
3,4,5-Trimethoxyamphetamine (7390)............... I
4-Bromo-2,5-dimethoxyamphetamine (7391).......... I
4-Bromo-2,5-dimethoxyphenethylamine (7392)....... I
4-Methyl-2,5-dimethoxyamphetamine (7395)......... I
2,5-Dimethoxyamphetamine (7396).................. I
JWH-398 (7398)................................... I
2,5-Dimethoxy-4-ethylamphetamine (7399).......... I
3,4-Methylenedioxyamphetamine (7400)............. I
5-Methoxy-3,4-methylenedioxyamphetamine (7401)... I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)... I
3,4-Methylenedioxy-N-ethylamphetamine (7404)..... I
3,4-Methylenedioxymethamphetamine (7405)......... I
4-Methoxyamphetamine (7411)...................... I
5-Methoxy-N-N-dimethyltryptamine (7431).......... I
Alpha-methyltryptamine (7432).................... I
Bufotenine (7433)................................ I
Diethyltryptamine (7434)......................... I
Dimethyltryptamine (7435)........................ I
Psilocybin (7437)................................ I
Psilocyn (7438).................................. I
5-Methoxy-N,N-diisopropyltryptamine (7439)....... I
N-Ethyl-1-phenylcyclohexylamine (7455)........... I
N-Benzylpiperazine (7493)........................ I
2C-D (7508)...................................... I
2C-E (7509)...................................... I
2C-H (7517)...................................... I
2C-I (7518)...................................... I
2C-C (7519)...................................... I
2C-N (7521)...................................... I
2C-P (7524)...................................... I
2C-T-4 (7532).................................... I
MDPV (7535)...................................... I
Methylone (7540)................................. I
AM-694 (7694).................................... I
Desmorphine (9055)............................... I
Dihydromorphine (9145)........................... I
Heroin (9200).................................... I
Morphine-N-oxide (9307).......................... I
Normorphine (9313)............................... I
Tilidine (9750).................................. I
Amphetamine (1100)............................... II
Methamphetamine (1105)........................... II
Lisdexamfetamine (1205).......................... II
Pentobarbital (2270)............................. II
Phencyclidine (7471)............................. II
Phenylacetone (8501)............................. II
Codeine (9050)................................... II
Dihydrocodeine (9120)............................ II
Oxycodone (9143)................................. II
Hydromorphone (9150)............................. II
Hydrocodone (9193)............................... II
Levomethorphan (9210)............................ II
Meperidine (9230)................................ II
Meperidine intermediate-B (9233)................. II
Methadone (9250)................................. II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300).................................. II
Thebaine (9333).................................. II
Oxymorphone (9652)............................... II
[[Page 32324]]
Sufentanil (9740)................................ II
Fentanyl (9801).................................. II
------------------------------------------------------------------------
The company plans to manufacture reference standards for
distribution to their research and forensics customers.
In reference to drug code 7360 (Marihuana), the company plans to
bulk manufacture cannabidiol as a synthetic intermediate. This
controlled substance will be further synthesized to bulk manufacture a
synthetic tetrahydrocannabinol (7370). No other activity for this drug
code is authorized for this registration.
No comments or objections have been received.
Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator.
[FR Doc. 2014-12952 Filed 6-3-14; 8:45 am]
BILLING CODE 4410-09-P
